Relationship between blood glucose levels and hepatic Fto mRNA expression in mice

Biochemical and Biophysical Research Communications

Volumn 400, Issue 4, 2010, Pages 713-717

  Poritsanos, Nicole J ^a   Lew, Pei San ^a   Mizuno, Tooru M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Gene expression; Gluconeogenesis; Glucose; Nutrient; Obesity

Indexed keywords

FAT MASS AND OBESITY ASSOCIATED PROTEIN; GLUCOSE; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; FEEDBACK SYSTEM; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INSULIN RESISTANCE; MALE; METABOLISM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; LIVER; MALE; MICE; MICE, INBRED C57BL; PROTEINS; RNA, MESSENGER;

MUS;

EID: 77957277779     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.133     Document Type: Article

References (25)

1. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., Perry J.R., Elliott K.S., Lango H., Rayner N.W., Shields B., Harries L.W., Barrett J.C., Ellard S., Groves C.J., Knight B., Patch A.M., Ness A.R., Ebrahim S., Lawlor D.A., Ring S.M., Ben-Shlomo Y., Jarvelin M.R., Sovio U., Bennett A.J., Melzer D., Ferrucci L., Loos R.J., Barroso I., Wareham N.J., Karpe F., Owen K.R., Cardon L.R., Walker M., Hitman G.A., Palmer C.N., Doney A.S., Morris A.D., Smith G.D., Hattersley A.T., McCarthy M.I. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894.
2. Fawcett K.A., Barroso I. The genetics of obesity: FTO leads the way. Trends Genet. 2010, 26:266-274.
3. Wahlen K., Sjolin E., Hoffstedt J. The common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysis. J. Lipid Res. 2008, 49:607-611.
4. Grunnet L.G., Nilsson E., Ling C., Hansen T., Pedersen O., Groop L., Vaag A., Poulsen P. Regulation and function of FTO mRNA expression in human skeletal muscle and subcutaneous adipose tissue. Diabetes 2009, 58:2402-2408.
5. Grunnet L.G., Brons C., Jacobsen S., Nilsson E., Astrup A., Hansen T., Pedersen O., Poulsen P., Quistorff B., Vaag A. Increased recovery rates of phosphocreatine and inorganic phosphate after isometric contraction in oxidative muscle fibers and elevated hepatic insulin resistance in homozygous carriers of the A-allele of FTO rs9939609. J. Clin. Endocrinol. Metab. 2009, 94:596-602.
6. Zabena C., Gonzalez-Sanchez J.L., Martinez-Larrad M.T., Torres-Garcia A., Alvarez-Fernandez-Represa J., Corbaton-Anchuelo A., Perez-Barba M., Serrano-Rios M. The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients. Obes. Surg. 2009, 19:87-95.
7. Kloting N., Schleinitz D., Ruschke K., Berndt J., Fasshauer M., Tonjes A., Schon M.R., Kovacs P., Stumvoll M., Bluher M. Inverse relationship between obesity and FTO gene expression in visceral adipose tissue in humans. Diabetologia 2008, 51:641-647.
8. Jowett J.B., Curran J.E., Johnson M.P., Carless M.A., Goring H.H., Dyer T.D., Cole S.A., Comuzzie A.G., MacCluer J.W., Moses E.K., Blangero J. Genetic variation at the FTO locus influences RBL2 gene expression. Diabetes 2010, 59:726-732.
9. Bassols J., Prats-Puig A., Vázquez-Ruíz M., García-González M.M., Martínez-Pascual M., Avellí P., Martínez-Martínez R., Fàbrega R., Colomer-Virosta C., Soriano-Rodríguez P., Díaz M., de Zegher F., Ibánez L., López-Bermejo A. Placental FTO expression relates to fetal growth. Int. J. Obes. 2010.
10. Boissel S., Reish O., Proulx K., Kawagoe-Takaki H., Sedgwick B., Yeo G.S., Meyre D., Golzio C., Molinari F., Kadhom N., Etchevers H.C., Saudek V., Farooqi I.S., Froguel P., Lindahl T., O'Rahilly S., Munnich A., Colleaux L. Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. Am. J. Hum. Genet. 2009, 85:106-111.
11. Meyre D., Proulx K., Kawagoe-Takaki H., Vatin V., Gutierrez-Aguilar R., Lyon D., Ma M., Choquet H., Horber F., Van Hul W., Van Gaal L., Balkau B., Visvikis-Siest S., Pattou F., Farooqi I.S., Saudek V., O'Rahilly S., Froguel P., Sedgwick B., Yeo G.S. Prevalence of loss-of-function FTO mutations in lean and obese individuals. Diabetes 2010, 59:311-318.
12. Fischer J., Koch L., Emmerling C., Vierkotten J., Peters T., Bruning J.C., Ruther U. Inactivation of the Fto gene protects from obesity. Nature 2009, 458:894-898.
13. Church C., Lee S., Bagg E.A., McTaggart J.S., Deacon R., Gerken T., Lee A., Moir L., Mecinovic J., Quwailid M.M., Schofield C.J., Ashcroft F.M., Cox R.D. A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. PLoS Genet. 2009, 5:e1000599.
14. Tung Y.C., Ayuso E., Shan X., Bosch F., O'Rahilly S., Coll A.P., Yeo G.S. Hypothalamic-specific manipulation of Fto, the ortholog of the human obesity gene FTO, affects food intake in rats. PLoS One 2010, 5:e8771.
15. Villalobos-Comparan M., Teresa Flores-Dorantes M., Teresa Villarreal-Molina M., Rodriguez-Cruz M., Garcia-Ulloa A.C., Robles L., Huertas-Vazquez A., Saucedo-Villarreal N., Lopez-Alarcon M., Sanchez-Munoz F., Dominguez-Lopez A., Gutierrez-Aguilar R., Menjivar M., Coral-Vazquez R., Hernandez-Stengele G., Vital-Reyes V.S., Acuna-Alonzo V., Romero-Hidalgo S., Ruiz-Gomez D.G., Riano-Barros D., Herrera M.F., Gomez-Perez F.J., Froguel P., Garcia-Garcia E., Teresa Tusie-Luna M., Aguilar-Salinas C.A., Canizales-Quinteros S. The FTO gene is associated with adulthood obesity in the Mexican population. Obesity (Silver Spring) 2008, (16):2296-2301.
16. Samaras K., Botelho N.K., Chisholm D.J., Lord R.V. Subcutaneous and visceral adipose tissue FTO gene expression and adiposity, insulin action, glucose metabolism, and inflammatory adipokines in type 2 diabetes mellitus and in health. Obes. Surg. 2010, 20:108-113.
17. Poritsanos N.J., Wong D., Vrontakis M.E., Mizuno T.M. Regulation of hepatic PPARgamma2 and lipogenic gene expression by melanocortin. Biochem. Biophys. Res. Commun. 2008, 376:384-388.
18. Gerken T., Girard C.A., Tung Y.C., Webby C.J., Saudek V., Hewitson K.S., Yeo G.S., McDonough M.A., Cunliffe S., McNeill L.A., Galvanovskis J., Rorsman P., Robins P., Prieur X., Coll A.P., Ma M., Jovanovic Z., Farooqi I.S., Sedgwick B., Barroso I., Lindahl T., Ponting C.P., Ashcroft F.M., O'Rahilly S., Schofield C.J. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 2007, 318:1469-1472.
19. Fredriksson R., Hagglund M., Olszewski P.K., Stephansson O., Jacobsson J.A., Olszewska A.M., Levine A.S., Lindblom J., Schioth H.B. The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology 2008, 149:2062-2071.
20. Stratigopoulos G., Padilla S.L., LeDuc C.A., Watson E., Hattersley A.T., McCarthy M.I., Zeltser L.M., Chung W.K., Leibel R.L. Regulation of Fto/Ftm gene expression in mice and humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294:R1185-R1196.
21. Kahn C.R., Lauris V., Koch S., Crettaz M., Granner D.K. Acute and chronic regulation of phosphoenolpyruvate carboxykinase mRNA by insulin and glucose. Mol. Endocrinol. 1989, 3:840-845.
22. Meyer S., Höppner W., Seitz H.J. Transcriptional and post-transcriptional effects of glucose on liver phosphoenolpyruvate-carboxykinase gene expression. Eur. J. Biochem. 1991, 202:985-991.
23. Scott D.K., O'Doherty R.M., Stafford J.M., Newgard C.B., Granner D.K. The repression of hormone-activated PEPCK gene expression by glucose is insulin-independent but requires glucose metabolism. J. Biol. Chem. 1998, 273:24145-24151.
24. Sanchez-Pulido L., Andrade-Navarro M.A. The FTO (fat mass and obesity associated) gene codes for a novel member of the non-heme dioxygenase superfamily. BMC Biochem. 2007, 8:23.
25. Jia G., Yang C.G., Yang S., Jian X., Yi C., Zhou Z., He C. Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO. FEBS Lett. 2008, 582:3313-3319.